Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders.
Manier S, Salem KZ, Liu D, Ghobrial IM. Manier S, et al. Am Soc Clin Oncol Educ Book. 2016;35:e400-6. doi: 10.1200/EDBK_159010. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249747 Free article. Review.
Multiple myeloma (MM) is an incurable disease that progresses from a premalignant stage termed monoclonal gammopathy of undetermined significance (MGUS) and an intermediate stage of smoldering multiple myeloma (SMM). Recent major advances in therapy with more effect …
Multiple myeloma (MM) is an incurable disease that progresses from a premalignant stage termed monoclonal gammopathy of undetermined …
Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AbetaPP(swe)/PS1 mice.
O'Neal-Moffitt G, Delic V, Bradshaw PC, Olcese J. O'Neal-Moffitt G, et al. Mol Neurodegener. 2015 Jul 11;10:27. doi: 10.1186/s13024-015-0027-6. Mol Neurodegener. 2015. PMID: 26159703 Free PMC article.
BACKGROUND: Alzheimer's disease (AD) underlies dementia for millions of people worldwide, and its occurrence is set to double in the next 20 years. ...CONCLUSIONS: These findings demonstrate that prophylactic MEL significantly reduces AD neuropathology and associate …
BACKGROUND: Alzheimer's disease (AD) underlies dementia for millions of people worldwide, and its occurrence is set to double …